GILEAD SCIENCES, INC.

Trading Ideas Gilead Sciences, Inc.

Equities

GILD

US3755581036

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 17:06:38 13/06/2025 BST			5-day change	1st Jan Change
110.17 ^USD	-1.68%		-2.04%	+19.26%

06-11	Gilead Sciences' Lenacapavir Provides 'Solid' Switching Opportunities for Current PrEP Users, RBC Says	MT
06-11	RBC Capital Raises Price Target on Gilead Sciences to $95 From $92, Keeps Sector Perform Rating	MT

Trading Ideas

GILEAD SCIENCES, INC.: A medium term support level to take advantage of	07/10/20
GILEAD SCIENCES, INC.: Volatility should make a big comeback	03/02/20
GILEAD SCIENCES, INC.: A valuable trading opportunity	29/12/14
GILEAD SCIENCES, INC.: Continuation of the bullish trend	27/08/14
GILEAD SCIENCES, INC.: A "V bottom" takes shape	27/05/14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

More Top / Flop

Rankings

More Top / Flop

Currency / Forex

Commodities

Cryptocurrencies

Cryptocurrencies

As early as today, start finding the best investment opportunities!